Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

LLY

Lilly(Eli) & Co

Nov 05 • 11:50AM ET

950.45

+43.59 4.81 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: NVO JNJ ABBV MRK AZN AMGN PFE SNY BMY GSK

| Held by: VTI VOO IVV SPY VUG XLV VIG IWF QUAL VHT

Scroll to Statements

Index	S&P 500	P/E	47.01	EPS (ttm)	20.22	Insider Own	10.21%	Shs Outstand	945.84M	Perf Week	16.83%
Market Cap	898.54B	Forward P/E	30.63	EPS next Y	31.03	Insider Trans	-2.11%	Shs Float	848.87M	Perf Month	12.66%
Enterprise Value	931.19B	PEG	1.11	EPS next Q	7.02	Inst Own	73.94%	Short Float	0.81%	Perf Quarter	48.31%
Income	18.41B	P/S	15.12	EPS this Y	79.91%	Inst Trans	-0.45%	Short Ratio	1.51	Perf Half Y	22.37%
Sales	59.42B	P/B	37.78	EPS next Y	32.78%	ROA	19.33%	Short Interest	6.84M	Perf YTD	23.12%
Book/sh	25.16	P/C	90.64	EPS next 5Y	42.35%	ROE	96.82%	52W High	935.62 1.58%	Perf Year	16.06%
Cash/sh	10.49	P/FCF	96.91	EPS past 3/5Y	24.14% 18.77%	ROIC	28.47%	52W Low	623.78 52.37%	Perf 3Y	162.49%
Dividend Est.	5.92 (0.62%)	EV/EBITDA	32.92	Sales past 3/5Y	16.73% 15.08%	Gross Margin	83.03%	Volatility	3.98% 2.61%	Perf 5Y	617.05%
Dividend TTM	5.80 (0.61%)	EV/Sales	15.67	EPS Y/Y TTM	120.94%	Oper. Margin	44.41%	ATR (14)	25.65	Perf 10Y	1044.16%
Dividend Ex-Date	Nov 14, 2025	Quick Ratio	1.24	Sales Y/Y TTM	45.41%	Profit Margin	30.99%	RSI (14)	79.42	Recom	1.58
Dividend Gr. 3/5Y	15.21% 15.05%	Current Ratio	1.55	EPS Q/Q	479.29%	SMA20	13.43%	Beta	0.38	Target Price	948.42
Payout	44.39%	Debt/Eq	1.79	Sales Q/Q	53.87%	SMA50	19.90%	Rel Volume	1.92	Prev Close	906.86
Employees	47000	LT Debt/Eq	1.72	Earnings	Oct 30 BMO	SMA200	20.08%	Avg Volume	4.54M	Price	950.45
IPO	Jul 09, 1970	Option/Short	Yes / Yes	EPS/Sales Surpr.	23.33% 9.64%	Trades		Volume	3,404,140	Change	4.81%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-20-25	Reiterated	BMO Capital Markets	Outperform	$840 → $930
Oct-14-25	Upgrade	Erste Group	Hold → Buy
Sep-17-25	Downgrade	Berenberg	Buy → Hold	$830
Aug-27-25	Upgrade	HSBC Securities	Reduce → Hold	$700
Aug-18-25	Downgrade	Daiwa Securities	Outperform → Neutral	$700
Aug-07-25	Downgrade	Leerink Partners	Outperform → Market Perform	$715
Jun-05-25	Downgrade	Erste Group	Buy → Hold
Apr-28-25	Downgrade	HSBC Securities	Buy → Reduce	$1150 → $700
Apr-22-25	Initiated	Cantor Fitzgerald	Overweight	$975
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000
Oct-17-24	Initiated	Bernstein	Outperform	$1100
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025
Feb-21-24	Downgrade	DZ Bank	Buy → Hold	$820
Feb-16-24	Reiterated	Morgan Stanley	Overweight	$805 → $950
Dec-21-23	Downgrade	Daiwa Securities	Buy → Outperform	$660 → $610
Nov-09-23	Initiated	Deutsche Bank	Hold	$535
Oct-20-23	Resumed	UBS	Buy	$612 → $710
Aug-09-23	Upgrade	Jefferies	Hold → Buy	$408 → $615

Show Previous Ratings

Today 11:54AM	Novo Nordisk Slides as GLP-1 Fatigue and Pricing Risks Cloud 2025 Outlook (GuruFocus.com)
10:30AM	Novo Nordisk Q3 Earnings & Revenues Miss, GLP-1 Drugs Face US Hurdles (Zacks)
10:17AM	Novo Nordisk CFO On Metsera, Hims And Lilly, And Why 'Hyper Growth' Has Stalled (Investor's Business Daily)
09:50AM	Here's Why Eli Lilly (LLY) is a Strong Momentum Stock (Zacks)
09:00AM	Pharma ETF (IHE) Hit a 52-Week High (Zacks)
08:06AM	Loading…
08:06AM	Novo Nordisk Stock Falls After Earnings. It Cut Guidance on These Fears. (Barrons.com)
07:45AM	Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy (Motley Fool)
07:18AM	White House speaking with Novo Nordisk, Eli Lilly about selling some obesity drugs for $149/mo: WSJ (CNBC TV)
06:37AM	Eli Lilly asks European nations to scrap clawback taxes, FT says (TipRanks)
06:30AM	This Company Now Has the World's No. 1 Drug. Should You Invest $1,000? (Motley Fool)
05:51AM	Novo Nordisk lowers profit guidance in new CEO's maiden quarter (Reuters Videos)
05:00AM	Novo Nordisk Stock Up After Earnings. Guidance Cut on These Weight-Loss Drug Fears. (Barrons.com)
02:07AM	Novo Cuts Outlook Citing Lower Wegovy, Ozempic Sales (Bloomberg)
Nov-04-25 08:10PM	Billionaire Stanley Druckenmiller Dropped Nvidia and Palantir Stock and Is Piling into 2 Stocks Set to Win in One of the Decade's Hottest Growth Markets. (Motley Fool)
05:29PM	Obesity drugs may get Medicare access under deal with White House: reports (MarketWatch)
05:20PM	Loading…
05:20PM	Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play (MarketBeat)
04:30PM	Novo Nordisk Reports Earnings on Wednesday. What to Expect. (Barrons.com)
01:50PM	Trump Negotiating Deal With Ozempic Maker to Sell Some Weight-Loss Drugs for $149 (The Wall Street Journal)
09:45AM	Why Eli Lilly (LLY) is a Top Growth Stock for the Long-Term (Zacks)
09:15AM	International Markets and Lilly (LLY): A Deep Dive for Investors (Zacks)
09:00AM	Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know (Zacks)
07:45AM	Is Eli Lilly a Millionaire Maker? (Motley Fool)
07:18AM	Here's What Weighed on Eli Lilly and Company's (LLY) Performance (Insider Monkey)
04:47AM	Eli Lilly to invest $3bn in new Dutch manufacturing facility (Pharmaceutical Technology)
01:22AM	Are Wall Street Analysts Predicting Eli Lilly Stock Will Climb or Sink? (Barchart)
Nov-03-25 07:38PM	Analyst Report: Incyte Corporation (Morningstar Research)
05:11PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:31PM	Hims Shares Rise on Talks to Offer Novos New Obesity Pill (Bloomberg)
12:03PM	Pfizer Aligns With Trump on Drug Pricing In Its Bid for Biotech Metsera (Barrons.com)
11:41AM	Novo Nordisk Before Q3 Earnings: How Should Investors Play the Stock? (Zacks)
11:13AM	Loading…
11:13AM	Viking Therapeutics Could Be Pharmas Next Big Buyout Target (24/7 Wall St.)
08:30AM	Lilly plans to build a new 2.6 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide (PR Newswire)
08:28AM	2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon (Motley Fool)
05:00AM	Tidmarsh resigns from CDER; Kenvue to sell to Kimberly-Clark (BioPharma Dive)
04:45AM	Prediction: The Next Eli Lilly Might Already Be Trading Under $50 (Motley Fool)
Nov-02-25 10:10PM	Cantor Fitzgerald Reaffirms Price Target on Eli Lilly (LLY) Despite GLP-1 Setback (Insider Monkey)
10:09PM	Jim Cramer Admits Surprise at Eli Lilly's Rally After Strong GLP-1 Results (Insider Monkey)
10:58AM	Rethinking Your Portfolio: The Stocks That Could Outperform for Years (Motley Fool)
05:30AM	Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk (The Wall Street Journal)
Nov-01-25 03:29PM	Eli Lilly (LLY) Would Be Up More If The Market Weren't That Bad, Says Jim Cramer (Insider Monkey)
08:05AM	S&P 500 Giants JPMorgan, Eli Lilly Lead Five Stocks Near Buy Points (Investor's Business Daily)
07:00AM	Nvidia's dizzying week of dealmaking (Yahoo Finance)
Oct-31-25 07:18PM	After Market's Trick-Or-Treat October, Palantir And Robinhood Lead Big Earnings (Investor's Business Daily)
06:00PM	Chipotle, Eli Lilly, Caterpillar: Stocks That Moved on This Weeks News (The Wall Street Journal)
05:54PM	Stock Market Week Ahead: October Marks A 7-Year Best For The Nasdaq (Investor's Business Daily)
05:30PM	Busy earnings week recap: 'It's all looking pretty positive' (Yahoo Finance Video)
05:12PM	Earnings live: Amazon stock soars, Apple pares gains with earnings from AI players to come (Yahoo Finance)
01:38PM	A Winning Week for Stocks Masks Trouble Below the Surface (Barrons.com)
12:30PM	Why Eli Lilly is making weight-loss pills before regulatory approval (Yahoo Finance Video)
11:04AM	Analyst Report: Eli Lilly and Company (Morningstar Research)
10:28AM	Novo Nordisk cuts 9,000 jobs as it looks to new weight-loss drugs (Reuters Videos)
09:42AM	Company News for Oct 31, 2025 (Zacks)
08:03AM	Massive sales for weight loss drugs spur Eli Lillys Q3 (Pharmaceutical Technology)
07:50AM	Earnings live: Amazon stock soars, Apple CEO predicts 'best-ever' quarter; Exxon, Chevron post strong earnings (Yahoo Finance)
07:09AM	Health Care Roundup: Market Talk (The Wall Street Journal)
02:45AM	Corporate venture firms stepped in for drug startups during biotech funding pullback (BioPharma Dive)
01:30AM	Vertex Pharma's Stock Has Tumbled. Earnings Will Stop the Pain. (Barrons.com)
Oct-30-25 09:05PM	Eli Lilly and Co (LLY) Q3 2025 Earnings Call Highlights: Record Revenue Surge and Strategic ... (GuruFocus.com)
07:53PM	Meta investors think Mark Zuckerberg is living dangerously, says Jim Cramer (CNBC TV)
07:53PM	Jim Cramer recaps Thursday's slate of earnings and what they signal about the economy (CNBC TV)
06:53PM	Mizuho's Holtz talks what is behind Novo's bid for Metsera (CNBC TV)
06:00PM	The Day Pharmas Weight-Loss Gold Rush Intensified (The Wall Street Journal)
05:23PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:52PM	Stock Market Today: Nasdaq, S&P End Sharply Lower With Meta's Plunge (Investor's Business Daily)
04:41PM	Earnings live: Amazon stock soars, Apple CEO predicts 'best-ever' holiday quarter, Reddit and Coinbase rise (Yahoo Finance)
04:41PM	Earnings live: Amazon stock soars on AWS growth, Apple wavers, Reddit and Coinbase move higher (Yahoo Finance)
04:35PM	Stocks to Watch Thursday Recap: Eli Lilly, Metsera, Navan, Chipotle (The Wall Street Journal)
04:19PM	Eli Lilly Smashes Expectations In 'Arguably The Strongest Print' Of The Quarter (Investor's Business Daily)
04:09PM	Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera (Investor's Business Daily)
03:46PM	Stock Market Today: Nasdaq Slammed As Meta Dives; Apple, Amazon To Report Next (Live Coverage) (Investor's Business Daily)
02:30PM	Eli Lilly teams up with Walmart on Zepbound: CFO explains (Yahoo Finance Video)
02:11PM	Novo Nordisk Tries to Snatch a Weight-Loss Biotech From Pfizer. There Are Political Risks. (Barrons.com)
01:50PM	Eli Lilly (LLY) Stock Trades Up, Here Is Why (StockStory)
01:31PM	Bidding war rises over weight loss drug that could prevent Ozempic face (The Telegraph)
01:10PM	Nvidia & Eli Lilly supercomputer will 'accelerate' drug discovery (Yahoo Finance Video)
12:57PM	Lilly Beats on Q3 Earnings, Ups View, Mounjaro, Zepbound Drive Sales (Zacks)
12:12PM	Eli Lilly Stock Rises -- Blowout Earnings Smash Forecasts, Lifts 2025 Outlook (GuruFocus.com)
11:10AM	Earnings Data Deluge (Zacks)
10:51AM	Eli Lilly CEO: Seeing global demand for weight loss drug Mounjaro (CNBC TV)
10:41AM	Stocks to Watch Thursday: Eli Lilly, Metsera, Navan, Chipotle (The Wall Street Journal)
10:39AM	Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war (Associated Press Finance)
10:38AM	Pre-markets Down on Questions: Fed, Jobs & Q3 Earnings (Zacks)
10:30AM	Compared to Estimates, Lilly (LLY) Q3 Earnings: A Look at Key Metrics (Zacks)
10:25AM	Eli Lilly Blows Away Q3 Earnings Expectations (24/7 Wall St.)
10:08AM	AI boom drives trillion-dollar tech valuations and record bets on chipmakers (Reuters)
09:36AM	Analyst Report: Incyte Corporation (Morningstar Research)
09:25AM	Novo Nordisk's bid for Metsera, Eli Lilly boosts revenue outlook (Yahoo Finance Video)
09:22AM	Eli Lilly Stock Rises on Earnings as Investors Await Trump Drug Pricing Deal (Barrons.com)
09:09AM	Eli Lilly Tops Earnings Forecasts and Raises Outlook as Zepbound and Mounjaro Sales Surge (GuruFocus.com)
08:34AM	5 Things to Know Before the Stock Market Opens (Investopedia)
08:28AM	These Stocks Are Moving the Most Today: Microsoft, Alphabet, Meta, Nvidia, Lilly, Chipotle, Carvana, FMC, Roblox, and More (Barrons.com)
08:20AM	Novo Nordisk launches bidding war with Pfizer for obesity drugmaker Metsera (AFP)
08:19AM	Earnings live: Meta stock tumbles, Microsoft slides, and Alphabet jumps as Big Tech earnings pour in (Yahoo Finance)
08:09AM	Eli Lilly's stock jumps as Zepbound sales nearly triple at lower prices (MarketWatch)
07:57AM	Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings (The Wall Street Journal)
07:55AM	Eli Lilly (LLY) Q3 Earnings and Revenues Surpass Estimates (Zacks)
07:51AM	Eli Lilly ramps up orforglipron production with $1.2bn Puerto Rico site expansion (Pharmaceutical Technology)
07:22AM	Eli Lilly raises annual revenue guidance amid strong weight-loss drug demand (Investing.com)
07:20AM	Eli Lilly Raises Outlook on Soaring GLP-1 Demand (The Wall Street Journal)
07:11AM	Metsera Stock Soars. Novo Nordisk Looks to Outbid Pfizer for the Obesity-Drug Maker. (Barrons.com)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LILLY ENDOWMENT INC	10% Owner	Nov 03 '25	Sale	888.83	300,000	266,648,921	93,931,978	Nov 04 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 04 '25	Proposed Sale	896.53	220,000	197,236,600		Nov 04 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Oct 31 '25	Sale	863.35	301,342	260,165,031	94,231,978	Nov 03 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 03 '25	Proposed Sale	862.86	300,000	258,858,000		Nov 03 03:06 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Sale	863.24	3,658	3,157,722	94,533,320	Oct 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 09 '25	Sale	852.49	10,602	9,038,055	94,536,978	Oct 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Proposed Sale	855.35	305,000	260,881,750		Oct 10 02:57 PM
LILLY ENDOWMENT INC	10% Owner	Oct 08 '25	Sale	850.27	101,420	86,234,874	94,547,580	Oct 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 07 '25	Sale	848.01	26,795	22,722,401	94,649,000	Oct 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Sale	850.22	161,183	137,041,657	94,675,795	Oct 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 03 '25	Sale	837.93	192,404	161,220,401	94,836,978	Oct 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Proposed Sale	839.87	300,000	251,961,000		Oct 06 03:35 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Sale	821.55	112,596	92,503,361	95,029,382	Oct 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	821.47	215,822	177,290,448	95,141,978	Oct 02 04:56 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	794.15	135,193	107,363,016	95,357,800	Oct 02 04:55 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Proposed Sale	825.42	305,000	251,753,100		Oct 02 03:20 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Proposed Sale	763.00	295,000	225,085,000		Oct 01 04:08 PM
LILLY ENDOWMENT INC	10% Owner	Sep 30 '25	Sale	763.39	113,694	86,793,274	95,492,993	Oct 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 19 '25	Sale	763.10	23,665	18,058,643	95,606,687	Sep 22 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Sale	764.65	106,626	81,531,959	95,630,352	Sep 19 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Proposed Sale	760.13	300,000	228,039,000		Sep 18 03:04 PM
DONALD ZAKROWSKI	Officer	Aug 28 '25	Proposed Sale	734.17	2,000	1,468,340		Aug 28 04:19 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 28 '25	Sale	734.93	1,000	734,930	3,840	Aug 28 04:14 PM
Montarce Lucas	EVP & CFO	Aug 15 '25	Buy	691.79	715	494,627	14,685	Aug 15 04:13 PM
Alvarez Ralph	Director	Aug 13 '25	Buy	660.25	758	500,473	758	Aug 14 04:12 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Aug 13 '25	Buy	647.36	1,000	647,360	20,562	Aug 13 04:15 PM
Ricks David A	President, Chair, and CEO	Aug 12 '25	Buy	644.77	1,632	1,052,263	546,601	Aug 12 04:23 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Aug 12 '25	Buy	634.40	1,000	634,405	137,660	Aug 12 04:20 PM
Sulzberger Gabrielle	Director	Aug 12 '25	Buy	641.18	117	75,018	2,703	Aug 12 04:19 PM
Fyrwald J Erik	Director	Aug 12 '25	Buy	642.33	1,565	1,005,242	74,578	Aug 12 04:17 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Aug 11 '25	Sale	627.01	1,250	783,762	26,260	Aug 12 04:16 PM
JACKSON JAMERE	Director	Aug 08 '25	Buy	639.56	200	127,913	9,402	Aug 08 04:20 PM
Seymour Melissa	EVP, Global Quality	Aug 01 '25	Option Exercise	0.00	952	0	952	Aug 04 04:16 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Sale	805.07	280,000	225,419,259	95,736,978	Jul 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Proposed Sale	798.89	280,000	223,689,200		Jul 24 03:01 PM
Zakrowski Donald A	SVP, Finance, & CAO	May 27 '25	Sale	716.41	1,000	716,410	4,840	May 27 04:13 PM
Yuffa Ilya	EVP & President, LLY Int'l	May 14 '25	Sale	749.24	1,250	936,550	27,510	May 15 04:17 PM
Yuffa Ilya	Officer	May 14 '25	Proposed Sale	749.24	2,500	1,873,100		May 14 12:25 PM
DONALD ZAKROWSKI	Officer	Mar 13 '25	Proposed Sale	821.86	2,000	1,643,720		Mar 13 04:57 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 13 '25	Sale	818.24	1,000	818,240	5,840	Mar 13 04:17 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Sale	928.76	220,000	204,326,151	96,016,978	Mar 04 04:00 PM
Dozier Eric	EVP, Chief People Officer	Mar 01 '25	Option Exercise	0.00	2,403	0	10,905	Mar 03 04:53 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Mar 01 '25	Option Exercise	0.00	2,837	0	41,009	Mar 03 04:51 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Proposed Sale	920.63	220,000	202,538,600		Mar 03 03:34 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Sale	903.07	225,000	203,190,794	96,236,978	Feb 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 24 '25	Sale	883.97	60,432	53,419,955	96,461,978	Feb 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Proposed Sale	881.40	225,000	198,315,000		Feb 25 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 21 '25	Sale	882.70	99,452	87,786,505	96,522,410	Feb 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 20 '25	Sale	877.99	14,685	12,893,353	96,621,862	Feb 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 19 '25	Sale	878.45	9,985	8,771,285	96,636,547	Feb 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Sale	879.52	35,446	31,175,396	96,646,532	Feb 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Proposed Sale	872.97	220,000	192,053,400		Feb 13 03:43 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 10 '25	Sale	863.21	5,000	4,316,065	117,888	Feb 12 04:15 PM
Skovronsky Daniel	Officer	Feb 10 '25	Proposed Sale	863.19	5,000	4,315,954		Feb 10 11:44 AM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Sale	874.13	210,000	183,567,262	96,681,978	Feb 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Proposed Sale	842.18	210,000	176,857,800		Feb 06 04:04 PM
Yuffa Ilya	EVP & President, LLY Int'l	Feb 01 '25	Option Exercise	0.00	3,269	0	23,071	Feb 04 04:28 PM
White Anne E.	EVP & Pres, Lilly Neuroscience	Feb 01 '25	Option Exercise	0.00	3,269	0	68,838	Feb 04 04:27 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Feb 01 '25	Option Exercise	0.00	3,023	0	14,868	Feb 04 04:26 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 01 '25	Option Exercise	0.00	8,989	0	126,892	Feb 04 04:25 PM
Ricks David A	President, Chair, and CEO	Feb 01 '25	Option Exercise	0.00	26,561	0	496,385	Feb 04 04:24 PM
Rau Diogo	EVP & CIDO	Feb 01 '25	Option Exercise	0.00	3,269	0	14,370	Feb 04 04:23 PM
Jonsson Patrik	EVP&Pres, CardMetHlth, LLY USA	Feb 01 '25	Option Exercise	0.00	3,433	0	48,016	Feb 04 04:23 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '25	Option Exercise	0.00	2,861	0	33,479	Feb 04 04:21 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '25	Option Exercise	0.00	4,904	0	20,683	Feb 04 04:19 PM
Zakrowski Donald A	Officer	Nov 08 '24	Proposed Sale	803.38	900	723,042		Nov 08 04:54 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 08 '24	Sale	803.38	900	723,042	5,480	Nov 08 04:18 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your FINVIZ experience